ArticleCancer research and treatment2016

Clinical Characteristics and Continued Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Administration in EGFR-mutated Non-Small Cell Lung Cancer with Skeletal Metastasis.

Sook-Hee Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.